Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL18066386 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL303199 | 0.95 | LMNA (0.38) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL293348 | 0.94 | SLC34A1 (0.42) | LMNASLC34A1 | |
| Phosphoric Acid SCHEMBL29608831 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL262223 | 0.94 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL29373778 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL19210854 | 0.89 | SLC34A1 (0.39) | LMNASLC34A1 | |
| Phosphoric Acid SCHEMBL3798147 | 0.89 | LMNA (0.40) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL525243 | 0.89 | LMNA (0.40) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL8208121 | 0.89 | LMNA (0.40) | LMNASLC34A1KDM4ECYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3846863-B1 | IMPLANT WITH CERAMIC COATING, METHOD OF FORMING AN IMPLANT, AND METHOD OF APPLYING A CERAMIC COATING | BIOCERA MEDICAL LTD (GB) | 2025-06-25 | — | — | EP | claimed |
| CN-120059628-A | Dampproof antibacterial hot melt adhesive and preparation method thereof | 云浮市骏驰新材料科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-118996855-B | Fabric fiber with antibacterial function and preparation process thereof | 北京布逸昊服装服饰有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119367587-A | Antibacterial silica gel and preparation process thereof | 振德医疗用品股份有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-119074645-A | Burn dressing capable of preventing sepsis and preparation method thereof | 浙江大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118496776-B | Antibacterial protective film for automobile and preparation method thereof | 广州鸿图新材料科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-118996855-A | Fabric fiber with antibacterial function and preparation process thereof | 北京布逸昊服装服饰有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-221600407-U | Novel medical dressing of hydrocolloid | 江苏弘生生物工程有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-118496776-A | Antibacterial protective film for automobile and preparation method thereof | 广州鸿图新材料科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-113980185-B | Amorphous silver-containing long-acting antibacterial hydrogel dressing with photocrosslinking curing function and preparation method thereof | 河南汇博医疗股份有限公司 | 2023-09-15 | — | — | CN | claimed |
| US-20050227016-A1 | Container for inhibiting microbial growth in liquid nutrients | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | claimed |
| US-20050226913-A1 | Article for inhibiting microbial growth in physiological fluids | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | claimed |
| US-20050224417-A1 | Use of derivatized nanoparticles to minimize growth of micro-organisms in hot filled drinks | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | claimed |
| US-20050224425-A1 | Container for inhibiting microbial growth in liquid nutrients | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | claimed |
| US-20050224423-A1 | Container for inhibiting microbial growth in liquid nutrients | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | claimed |
| US-20050224419-A1 | Use of derivatized nanoparticles to minimize growth of micro-organisms in hot filled drinks | EASTMAN KODAK COMPANY | 2005-10-13 | — | — | US | claimed |
| WO-2005061022-A2 | ANTIMICROBIAL WEB FOR APPLICATIONS TO A SURFACE | EASTMAN KODAK COMPANY (US) | 2005-07-07 | — | — | WO | claimed |
| US-20050129929-A1 | Antimicrobial metal-ion sequestering web for application to a surface | EASTMAN KODAK COMPANY | 2005-06-16 | — | — | US | claimed |
| US-20050129937-A1 | Antimicrobial web for application to a surface | EASTMAN KODAK COMPANY | 2005-06-16 | — | — | US | claimed |
| CN-1541536-A | Inorganic antiseptic of phosphate containing high valence Ag and its preparation method | 西安康旺抗菌科技股份有限公司 | 2004-11-03 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050226913-A1 | Article for inhibiting microbial growth in physiological fluids | FABP2, FABP1, MIF | LMNA 4542/4885SLC34A1 72/4885KDM4E 4563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.